MetaADEDB 2.0 @ LMMD
Amlodipine besylate and benazepril hydrochloride
(SJSNKICFTZWKLT-KEHAGZLWSA-N)
Structure
SMILES
OS(=O)(=O)c1ccccc1.CCOC(=O)[C@@H](N[C@H]1CCc2c(N(C1=O)CC(=O)O)cccc2)CCc1ccccc1.NCCOCC1=C(C(=O)OCC)C(C(=C(N1)C)C(=O)OC)c1ccccc1Cl.Cl
Molecular Formula:
C50H60Cl2N4O13S
Molecular Weight:
1028.000
Log P:
9.1405
Hydrogen Bond Acceptor:
17
Hydrogen Bond Donor:
6
TPSA:
258.57
CAS Number(s):
858669-53-1
Synonym(s)
1.
Amlodipine besylate and benazepril hydrochloride
External Link(s)
PubChem Compound9876522
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 12US FAERS
2Product substitution issueFAERS: 7US FAERS
3Abdominal discomfortFAERS: 4US FAERS
4HeadacheFAERS: 4US FAERS
5NauseaFAERS: 4US FAERS
6Completed SuicideFAERS: 3US FAERS
7MalaiseFAERS: 3US FAERS
8AngioedemaFAERS: 2US FAERS
9AnuriaFAERS: 2US FAERS
10Blood pressure inadequately controlledFAERS: 2US FAERS
11Cardiac ArrestFAERS: 2US FAERS
12Chest PainFAERS: 2US FAERS
13DyspepsiaFAERS: 2US FAERS
14FatigueFAERS: 2US FAERS
15Feeling abnormalFAERS: 2US FAERS
16HypersensitivityFAERS: 2US FAERS
17HypotensionFAERS: 2US FAERS
18Joint swellingFAERS: 2US FAERS
19LethargyFAERS: 2US FAERS
20Pharmaceutical product complaintFAERS: 2US FAERS
21Product taste abnormalFAERS: 2US FAERS
22Toxicity to various agentsFAERS: 2US FAERS
23Unresponsive to stimuliFAERS: 2US FAERS
24UrticariaFAERS: 2US FAERS
25VomitingFAERS: 2US FAERS
26Accidental exposure to product by childFAERS: 1US FAERS
27AgeusiaFAERS: 1US FAERS
28AnxietyFAERS: 1US FAERS
29ArteriosclerosisFAERS: 1US FAERS
30ArthralgiaFAERS: 1US FAERS
31Bone painFAERS: 1US FAERS
32CardiomegalyFAERS: 1US FAERS
33ChokingFAERS: 1US FAERS
34Coronary Artery DiseaseFAERS: 1US FAERS
35DizzinessFAERS: 1US FAERS
36DysgeusiaFAERS: 1US FAERS
37Food AllergyFAERS: 1US FAERS
38GoutFAERS: 1US FAERS
39Impaired work abilityFAERS: 1US FAERS
40Incorrect drug administration durationFAERS: 1US FAERS
41InfectionFAERS: 1US FAERS
42Lip swellingFAERS: 1US FAERS
43Medication residue presentFAERS: 1US FAERS
44Migraine with AuraFAERS: 1US FAERS
45Milk AllergyFAERS: 1US FAERS
46PalpitationsFAERS: 1US FAERS
47Peripheral swellingFAERS: 1US FAERS
48Product quality issueFAERS: 1US FAERS
49Pulmonary EosinophiliaFAERS: 1US FAERS
50Reaction to drug excipientsFAERS: 1US FAERS
51RetchingFAERS: 1US FAERS
52Visual ImpairmentFAERS: 1US FAERS
53Wrong technique in drug usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.